Jade Biosciences, Inc. JBIO
Set alert
14.63 USD +0.70 +5.03%
As of Nov 3, 11:04 AM ET
14.08 Day range 14.85
8.95 52-week range 26.85
- YTD
- -5.18%
- 1 year
- +54.49%
- Open
- 14.11
- Prev close
- 13.93
- Mkt cap
- 930.43M
- Vol
- 570.49K
- Avg vol
- 899.89K
- EPS
- -1.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.08
- High
- 14.85
- Forward P/E
- -6.29
- Beta
- 0.00
- Short ratio
- 12.92
- Inst. own
- 116.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 20.55
- 200-d avg
- 18.29
- 1y target
- 50.13
Analyst view
Consensus: none
Price target (mean) 50.13 +242.6% upside
Now 14.63
- Target (low)
- 40.00
- Target (mean)
- 50.13
- Target (high)
- 77.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy0
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.78642 | -0.78642 – -0.78642 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -0.80808 | -0.80808 – -0.80808 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -2.93 | -2.93 – -2.93 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -2.66 | -2.66 – -2.66 | -2.93 | +9.2% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 11, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 10, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 15, 2026 | UBS | Initiated | — | Buy |
| Jun 2, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jun 1, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 1, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 27, 2026 | BTIG | Reiterated | Buy | Buy |
| May 11, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 11, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 25, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 16, 2026 | BTIG | Maintained | Buy | Buy |
| Mar 11, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 9, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jan 7, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 25, 2025 | Clear Street | Initiated | — | Buy |
| Nov 18, 2025 | Guggenheim | Maintained | Buy | Buy |
| Oct 9, 2025 | BTIG | Initiated | — | Buy |
| Aug 14, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Jun 16, 2025 | Guggenheim | Upgrade | Neutral | Buy |
| May 15, 2025 | Wedbush | Reiterated | Outperform | Outperform |
| May 7, 2025 | Wedbush | Initiated | — | Outperform |